Patents by Inventor Atsuhiro Kanda

Atsuhiro Kanda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SINGLE-STRANDED NUCLEIC ACID MOLECULE INHIBITING EXPRESSION OF PRORENIN GENE OR PRORENIN RECEPTOR GENE, AND USE THEREOF
    Publication number: 20190010503
    Abstract: The present invention provides a single-stranded nucleic acid molecule inhibiting expression of a prorenin gene or a prorenin receptor gene, comprising only region (X), linker region (Lx) and region (Xc), wherein the aforementioned linker region (Lx) has a non-nucleotide structure comprising at least one of a pyrrolidine skeleton and a piperidine skeleton, and at least one of the aforementioned region (X) and the aforementioned region (Xc) comprises an expression inhibitory sequence comprising a nucleotide sequence consisting of at least 18 continuous nucleotides in any of an expression inhibitory sequence of a prorenin gene shown in SEQ ID NO: 1 to 5 and an expression inhibitory sequence of prorenin receptor gene shown in SEQ ID NO: 6 to 11.
    Type: Application
    Filed: December 29, 2016
    Publication date: January 10, 2019
    Applicants: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY, TOKYO MEDICAL UNIVERSITY, BONAC CORPORATION
    Inventors: Susumu ISHIDA, Atsuhiro KANDA, Masahiko KURODA, Hidekazu TOYOFUKU
  • MICROARRAY FOR EVALUATING EYE DISEASE, AND EVALUATION METHOD OF EYE DISEASE
    Publication number: 20160024582
    Abstract: The purpose of the present invention is to provide a method for objectively evaluating the state of eye disease in a test organism. Provided is a microarray for evaluating the state of eye disease. Further, this method for evaluating the state of eye disease in a test organism is characterized by detecting, from a sample taken from the test organism, at least one gene from a prescribed gene group and comparing the obtained detection result with a control.
    Type: Application
    Filed: April 8, 2014
    Publication date: January 28, 2016
    Applicant: MITSUBISHI RAYON CO., LTD.
    Inventors: Kenjiro IKUTA, Susumu ISHIDA, Atsuhiro KANDA
  • COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING MACULAR DEGENERATION
    Publication number: 20130266937
    Abstract: The present invention relates generally to biomarkers for macular degeneration. In particular, the present invention provides a plurality of biomarkers (e.g., polymorphisms and/or haplotypes) for monitoring and diagnosing macular degeneration. The compositions and methods of the present invention find use in diagnostic, therapeutic, research, and drug screening applications.
    Type: Application
    Filed: March 5, 2013
    Publication date: October 10, 2013
    Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Anand Swaroop, Goncalo Abecasis, Atsuhiro Kanda, Mingyao Li
  • COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING MACULAR DEGENERATION
    Publication number: 20090203001
    Abstract: The present invention relates generally to biomarkers for macular degeneration. In particular, the present invention provides a plurality of biomarkers (e.g., polymorphisms and/or haplotypes) for monitoring and diagnosing macular degeneration. The compositions and methods of the present invention find use in diagnostic, therapeutic, research, and drug screening applications.
    Type: Application
    Filed: August 25, 2008
    Publication date: August 13, 2009
    Applicant: The Regents of the University of Michigan
    Inventors: Anand Swaroop, Goncalo Abecasis, Mingyao Li, Atsuhiro Kanda